COVID-19
Cognitive, EEG, and MRI features in COVID-19 survivors
Neurological manifestations of COVID-19 worsen prognosis
New evidence for biological basis of “COVID-19 brain fog”
Impact of COVID-19 public health interventions
Telemedicine during COVID-19 pandemic highly appreciated
COVID vaccination especially important for dialysis patients
‘Startling’ heart attack finding in COVID patients
AD treatment during the pandemic: dupilumab does not raise COVID-19 infection risk
Lessons from the COVID-19 pandemic for IBD management
Impact of COVID-19 on screening for colorectal cancer
ACC issues consensus document on cardiovascular consequences of COVID-19
Alzheimer’s-like changes seen in COVID-19 patients’ brains
DLQI scores underestimated during lockdowns?
TNF blockers likely beneficial for psoriatic patients with COVID-19
Patients on immunomodulators need 2 COVID-19 vaccinations before seroconversion
COVID-19 vaccines seem safe, generally well tolerated in rheumatic, musculoskeletal diseases
Blood pressure control disrupted during the pandemic
Icosapent ethyl did not reduce the risk of hospitalisation in COVID-19
Neutral effect of P2Y12 inhibitors in non-critical COVID-19 hospitalisations
COVID-19 mRNA vaccination benefits outweigh the risk for myocarditis
Vaccine booster improves immune response in patients treated with rituximab
Vaccinated rheumatic patients carry increased risk for COVID-19 breakthrough infections
B-cell depleting medication increases COVID-19 breakthrough infection outcome risk
COVID-19 mRNA vaccine safe and tolerable in adults with autoimmune disease
Lupus patients less protected by COVID-19 vaccine
Laboratory and clinical signs 24h after hospitalisation predict MIS-C in children
MS patients at risk of hampered immune response after vaccination
Immunotherapy in MS does not influence COVID-19 severity and mortality
Anti-CD20 antibodies associated with worse COVID-19 outcomes
ECTRIMS-EAN consensus on vaccination in MS patients
Apixaban tops rivaroxaban for repeat-VTE protection in real-world analysis
Study reveals spectrum of COVID-19 brain complications
Cardiopulmonary exercise test helps define the cause of unexplained dyspnea in COVID long-haulers
Connecting, challenging, and empowering youth through their smartphone
Alcohol consumption during lockdown
Post-COVID-19 depression responds well to SSRIs
Impact of COVID-19 on patients with psychotic disorders
‘Glimpse of hope’ when anti-CD20 drugs limit vaccine antibodies
Dupilumab for atopic dermatitis linked with milder COVID-19 symptoms
Adequate response to SARS-CoV-2 vaccine in cancer patients
Cancer patients more likely to die from COVID-19 when hospital admittance is required
Third global survey of the ESMO Resilience Task Force
High COVID-19 mortality in Swiss cancer patients
Damaged skin as a possible transmission route for SARS-CoV-2
Anti-TNF therapy tied to better outcomes in IBD patients with COVID-19
Higher inflammation markers in COVID-19 patients with a first negative PCR test
Persistent fatigue following COVID-19
Risk of COVID-19-related morbidity and mortality in young and middle-aged adults
Dynamics of environmental pollution during and after COVID-19 lockdown
Telemedicine beneficial for headache care during the pandemic
Comparison of headaches after SARS-CoV-2 vaccination
Grey matter cortical changes in patients with persistent headache after COVID-19
Increased risk of cerebral venous thrombosis in COVID-19
Two-dose COVID-19 vaccination may not lead to flares in RA patients
More adults embraced at-home colorectal-cancer screening during pandemic
Serologic response to COVID-19 mRNA vaccine reduced in IBD patients on anti-TNFα
Rivaroxaban improves clinical outcomes in discharged COVID-19 patients
COVID-19: Thromboembolic risk reduction with therapeutic heparin dosing
Long COVID symptoms – Is ongoing cardiac damage the culprit?
UEGW 2021 Highlights Podcast
ECNP 2021 Highlights Podcast
EADV 2021 Highlights Podcast
COVID toes and seasonal chilblains share similar immune responses
B-cell-targeted therapy linked with severe COVID-19 among patients with arthritis
Increased risk of death in cardiac wait list patients seen early in pandemic
Psoriasis registries yield important data about COVID-19
COVID-19 affects patients and care
Vaccination feasible in people with psoriatic disease
Low COVID-19 risk for patients with psoriasis on biologic treatment
Lung-cancer trial enrollment takes a hit amid COVID-19
Vaccines induce antibodies despite cancer, immunocompromise
Telemedicine: Every light has its shadow
COVID-19-related HF: from systemic infection to cardiac inflammation
Increased COVID-19 mortality in patients with cardiorenal comorbidity
Myocardial infarction outcomes were significantly affected by the pandemic
COVID-19 in AF patients with HF: no higher mortality but longer hospital stay
Severe outcomes of COVID-19 in patients with dementia
First evidence of brainstem involvement in COVID-19
Intracerebral haemorrhage only slightly increases mortality in COVID-19 patients
Cognitive/behavioural alterations persistent after COVID-19
Neural base of persistent hyposmia after COVID-19
Neurological symptoms and complications of COVID-19 affect outcomes
COVID-19 patients with B-cell malignancies may deteriorate on bamlanivimab-etesevimab therapy
Decline in hospitalizations for heart attack and stroke persisted through 2020
Physiopathology of coagulopathy in haematological malignancies and COVID-19
Haemostatic abnormalities are associated with mortality in COVID-19
Mechanisms of COVID-19 vaccine-induced thrombotic thrombocytopenia
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: discovery and diagnosis
Rituximab or JAK inhibitors increase the risk of severe COVID-19
Immunomodulatory therapies for severe COVID-19: literature update
Hair shedding related to COVID-19 doesn’t last long
Vector-based vaccines likely more effective in patients on rituximab
Blistering eruptions, including bullous pemphigoid, seen after COVID vaccine
Methotrexate use tied to weakened antibody response after first Pfizer-BioNTech vaccine shot
Pfizer/BioNTech COVID-19 vaccine seems effective, safe in HCT, CART therapy patients
Dapagliflozin fails to show a significant protective effect in COVID-19
Therapeutic anticoagulation not superior to prophylactic anticoagulation in COVID-19
Atorvastatin does not reduce mortality in COVID-19
Does COPD plus COVID-19 equal higher mortality?
Association between positive airway pressure treatment adherence and COVID-19 infection rates
Antibody treatment for COVID-19: a combination is successful
Air pollution: an underestimated negative prognostic factor for COVID-19
Healthcare workers vulnerable to SARS-CoV-2 infections
Genetic risk variants responsible for COVID-19 predisposition
No increased risk of (severe) COVID-19 among IBD patients
SARS-CoV-2 may exploit injured kidney cells to cause infection, damage
Limited added value of ECG-based mortality prediction in COVID-19 patients using machine learning
The neurological impact of COVID-19
Chemosensory dysfunction often persistent after COVID-19
Pandemic results in decreased global stroke care
Stroke uncommon in critically ill COVID-19 patients
Non-invasive ventilation tied to higher mortality than CPAP in COVID-19 pneumonia
Psoriasis and hidradenitis suppurativa during COVID-19: keep calm and carry on
COVID-19 in children – cutaneous involvement is common
Psoriasis management in times of COVID-19: the knowledge is growing steadily
Cutaneous reactions after COVID-19 vaccination: an update
Patients with autoimmune disease may not be fully protected even after second COVID shot
Non-live COVID-19 vaccines likely safe, effective in MS patients, but immune response varies
mRNA COVID-19 vaccines effective in IBD patients receiving biological therapies
Do anti-CD20 DMTs cause worse COVID-19 outcomes in MS?
Transplant saves selected patients with irreversible COVID-19 lung disease
Pfizer-BioNTech COVID-19 vaccine appears safe in cancer patients on immunotherapy
COVID-19 outcomes no worse with congenital heart disease
COVID-19 impact on gastrointestinal cancer care
Treatment delay for cholangiocarcinoma adjuvant therapy does not affect OS
Outcomes with COVID-19 acute kidney injury worse than for other AKI patients
More complicated course of COVID-19 in leukaemia patients
Older age and imatinib treatment associated with COVID-19 mortality in CML
Allogeneic SARS-CoV-2-specific T cells to treat COVID-19
Fewer CV complications than expected in AHA COVID-19 Registry
Worse COVID-19 outcomes in younger obese patients
Effects of CVD in hospitalised COVID-19 patients
Meta-analyses: ACEI/ARB and COVID-19
Unfavourable outcomes for COVID-19 patients with AF and atrial flutter
COVID-19 survival poor for hematopoietic stem cell transplant recipients
COVID has led to a drop in lung cancer diagnosis, more deaths
COVID outcomes have improved over time in patients with rheumatic disease
COVID-19 in patients with rheumatic disease: most report mild disease
Poor disease control: a risk factor for severe COVID-19
No heightened outcome risk for rheumatic patients with COVID-19
Children with rheumatic disease have no greater risk of a COVID-19 infection
COVID-19 far more deadly than seasonal flu, large study confirms
Biologic psoriasis treatment and COVID-19 risk: Contradictory results
Much to be learned about COVID-19 and the skin
Anti-cytokine therapy normalizes ACE2 expression in IBD, may protect against COVID-19
COVID-19: Continuing versus suspending ACE inhibitors and ARBs
Risk factors for thromboembolism and bleeding in COVID-19: lessons from Wuhan
The Yale COVID-19 Cardiovascular Registry
COVID-19 treatments and the importance of randomised trials
COVID-19 infections: Bronchoscopy provides additional diagnostic certainty
COVID-19 vaccines: An ongoing race
COVID-19: What is the risk of reinfection?
COVID-19 App: The Dutch experience
Secondary pulmonary fibrosis: a possible long-term effect of severe COVID-19
COVID-19 survivors benefit from structured follow-up
Early pulmonary rehabilitation post-COVID-19 aids recovery
COVID-19-associated delays in aortic-valve replacement tied to worse outcomes
Treatment times of acute STEMI have increased with COVID-19 pandemic
Crosstalk between inflammation and coagulation in severe COVID-19 infections
COVID-19 associated with higher VTE rates relative to influenza
Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients
COVID-19 not associated with heightened VTE risk after discharge
